Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate in Schizophrenia
NCT00688324Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2008
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acamprosate in schizophrenia, schizoaffective disorder, sponsored by University of Maryland, Baltimore. Started Jun 2008; status: completed.
02
Drugs
acamprosate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00688324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688324.